AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis and fibrosis.
AGED Diagnostics has raised $250K in total funding. The most recent round was Seed. The last funding was announced in August 2025.
AGED Diagnostics's investors include TEDCO.
AGED Diagnostics is headquartered in Washington, United States.
AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis and fibrosis.
AGED Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AGED Diagnostics — Funding & Investors." VCBacked, August 19, 2025, https://www.vcbacked.co/company/aged-diagnostics. Accessed August 1, 2026.
VCBacked. (2025). AGED Diagnostics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/aged-diagnostics
{{cite web |title=AGED Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/aged-diagnostics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated